Comparison Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.65 USD | -1.68% |
|
-7.40% | +11.12% |
| Jul. 20 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| Jul. 07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | -1.07% | -7.40% | +11.12% | +25.16% | +52.30% | 5.93B |  |  | |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
